 | • レポートコード：MRC2-11QY04596 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、94ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は性腺性腺間質腫瘍治療のグローバル市場について調査・分析したレポートです。種類別（化学療法、放射線療法、手術、その他）市場規模、用途別（病院、診療所、がん研究センター、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別性腺性腺間質腫瘍治療の競争状況、市場シェア ・世界の性腺性腺間質腫瘍治療市場：種類別市場規模 2015年-2020年（化学療法、放射線療法、手術、その他） ・世界の性腺性腺間質腫瘍治療市場：種類別市場規模予測 2021年-2026年（化学療法、放射線療法、手術、その他） ・世界の性腺性腺間質腫瘍治療市場：用途別市場規模 2015年-2020年（病院、診療所、がん研究センター、その他） ・世界の性腺性腺間質腫瘍治療市場：用途別市場規模予測 2021年-2026年（病院、診療所、がん研究センター、その他） ・北米の性腺性腺間質腫瘍治療市場分析：米国、カナダ ・ヨーロッパの性腺性腺間質腫瘍治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの性腺性腺間質腫瘍治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の性腺性腺間質腫瘍治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの性腺性腺間質腫瘍治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Abbott、Danaher、Roche、BD、Boston Scientific、Johnson & Johnson、Bio-Rad、Merck Millipore、Agilent Technologies、Thermo Fisher Scientific、Qiagen、PerkinElmer、CooperSurgical ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes.
Market Analysis and Insights: Global Sex Cord Gonadal Stromal Tumor Treatment Market
The global Sex Cord Gonadal Stromal Tumor Treatment market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Sex Cord Gonadal Stromal Tumor Treatment Scope and Market Size
Sex Cord Gonadal Stromal Tumor Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Sex Cord Gonadal Stromal Tumor Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Abbott
Danaher
Roche
BD
Boston Scientific
Johnson & Johnson
Bio-Rad
Merck Millipore
Agilent Technologies
Thermo Fisher Scientific
Qiagen
PerkinElmer
CooperSurgical
Market segment by Type, the product can be split into
Chemotherapy
Radiotherapy
Surgery
Others
Market segment by Application, split into
Hospitals
Clinics
Cancer Research Centers
Others
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Sex Cord Gonadal Stromal Tumor Treatment Revenue
1.4 Market by Type
1.4.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Chemotherapy
1.4.3 Radiotherapy
1.4.4 Surgery
1.4.5 Others
1.5 Market by Application
1.5.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospitals
1.5.3 Clinics
1.5.4 Cancer Research Centers
1.5.5 Others
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Perspective (2015-2026)
2.2 Global Sex Cord Gonadal Stromal Tumor Treatment Growth Trends by Regions
2.2.1 Sex Cord Gonadal Stromal Tumor Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Sex Cord Gonadal Stromal Tumor Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Sex Cord Gonadal Stromal Tumor Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Sex Cord Gonadal Stromal Tumor Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Sex Cord Gonadal Stromal Tumor Treatment Players by Market Size
3.1.1 Global Top Sex Cord Gonadal Stromal Tumor Treatment Players by Revenue (2015-2020)
3.1.2 Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Sex Cord Gonadal Stromal Tumor Treatment Market Concentration Ratio
3.2.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Sex Cord Gonadal Stromal Tumor Treatment Revenue in 2019
3.3 Sex Cord Gonadal Stromal Tumor Treatment Key Players Head office and Area Served
3.4 Key Players Sex Cord Gonadal Stromal Tumor Treatment Product Solution and Service
3.5 Date of Enter into Sex Cord Gonadal Stromal Tumor Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Sex Cord Gonadal Stromal Tumor Treatment Historic Market Size by Type (2015-2020)
4.2 Global Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020)
5.2 Global Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size (2015-2020)
6.2 Sex Cord Gonadal Stromal Tumor Treatment Key Players in North America (2019-2020)
6.3 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020)
6.4 North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size (2015-2020)
7.2 Sex Cord Gonadal Stromal Tumor Treatment Key Players in Europe (2019-2020)
7.3 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020)
7.4 Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020)
8 China
8.1 China Sex Cord Gonadal Stromal Tumor Treatment Market Size (2015-2020)
8.2 Sex Cord Gonadal Stromal Tumor Treatment Key Players in China (2019-2020)
8.3 China Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020)
8.4 China Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Sex Cord Gonadal Stromal Tumor Treatment Market Size (2015-2020)
9.2 Sex Cord Gonadal Stromal Tumor Treatment Key Players in Japan (2019-2020)
9.3 Japan Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020)
9.4 Japan Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Size (2015-2020)
10.2 Sex Cord Gonadal Stromal Tumor Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020)
11 India
11.1 India Sex Cord Gonadal Stromal Tumor Treatment Market Size (2015-2020)
11.2 Sex Cord Gonadal Stromal Tumor Treatment Key Players in India (2019-2020)
11.3 India Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020)
11.4 India Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Sex Cord Gonadal Stromal Tumor Treatment Market Size (2015-2020)
12.2 Sex Cord Gonadal Stromal Tumor Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020)
12.4 Central & South America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Abbott
13.1.1 Abbott Company Details
13.1.2 Abbott Business Overview
13.1.3 Abbott Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.1.4 Abbott Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020))
13.1.5 Abbott Recent Development
13.2 Danaher
13.2.1 Danaher Company Details
13.2.2 Danaher Business Overview
13.2.3 Danaher Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.2.4 Danaher Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.2.5 Danaher Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.3.4 Roche Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.3.5 Roche Recent Development
13.4 BD
13.4.1 BD Company Details
13.4.2 BD Business Overview
13.4.3 BD Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.4.4 BD Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.4.5 BD Recent Development
13.5 Boston Scientific
13.5.1 Boston Scientific Company Details
13.5.2 Boston Scientific Business Overview
13.5.3 Boston Scientific Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.5.4 Boston Scientific Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.5.5 Boston Scientific Recent Development
13.6 Johnson & Johnson
13.6.1 Johnson & Johnson Company Details
13.6.2 Johnson & Johnson Business Overview
13.6.3 Johnson & Johnson Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.6.4 Johnson & Johnson Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.6.5 Johnson & Johnson Recent Development
13.7 Bio-Rad
13.7.1 Bio-Rad Company Details
13.7.2 Bio-Rad Business Overview
13.7.3 Bio-Rad Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.7.4 Bio-Rad Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.7.5 Bio-Rad Recent Development
13.8 Merck Millipore
13.8.1 Merck Millipore Company Details
13.8.2 Merck Millipore Business Overview
13.8.3 Merck Millipore Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.8.4 Merck Millipore Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.8.5 Merck Millipore Recent Development
13.9 Agilent Technologies
13.9.1 Agilent Technologies Company Details
13.9.2 Agilent Technologies Business Overview
13.9.3 Agilent Technologies Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.9.4 Agilent Technologies Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.9.5 Agilent Technologies Recent Development
13.10 Thermo Fisher Scientific
13.10.1 Thermo Fisher Scientific Company Details
13.10.2 Thermo Fisher Scientific Business Overview
13.10.3 Thermo Fisher Scientific Sex Cord Gonadal Stromal Tumor Treatment Introduction
13.10.4 Thermo Fisher Scientific Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
13.10.5 Thermo Fisher Scientific Recent Development
13.11 Qiagen
10.11.1 Qiagen Company Details
10.11.2 Qiagen Business Overview
10.11.3 Qiagen Sex Cord Gonadal Stromal Tumor Treatment Introduction
10.11.4 Qiagen Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
10.11.5 Qiagen Recent Development
13.12 PerkinElmer
10.12.1 PerkinElmer Company Details
10.12.2 PerkinElmer Business Overview
10.12.3 PerkinElmer Sex Cord Gonadal Stromal Tumor Treatment Introduction
10.12.4 PerkinElmer Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
10.12.5 PerkinElmer Recent Development
13.13 CooperSurgical
10.13.1 CooperSurgical Company Details
10.13.2 CooperSurgical Business Overview
10.13.3 CooperSurgical Sex Cord Gonadal Stromal Tumor Treatment Introduction
10.13.4 CooperSurgical Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020)
10.13.5 CooperSurgical Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Sex Cord Gonadal Stromal Tumor Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Sex Cord Gonadal Stromal Tumor Treatment Revenue
Table 3. Ranking of Global Top Sex Cord Gonadal Stromal Tumor Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Chemotherapy
Table 6. Key Players of Radiotherapy
Table 7. Key Players of Surgery
Table 8. Key Players of Others
Table 9. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 10. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 11. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 12. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Regions (2015-2020)
Table 13. Global Sex Cord Gonadal Stromal Tumor Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 14. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Regions (2021-2026)
Table 15. Market Top Trends
Table 16. Key Drivers: Impact Analysis
Table 17. Key Challenges
Table 18. Sex Cord Gonadal Stromal Tumor Treatment Market Growth Strategy
Table 19. Main Points Interviewed from Key Sex Cord Gonadal Stromal Tumor Treatment Players
Table 20. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue by Players (2015-2020) (Million US$)
Table 21. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Players (2015-2020)
Table 22. Global Top Sex Cord Gonadal Stromal Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sex Cord Gonadal Stromal Tumor Treatment as of 2019)
Table 23. Global Sex Cord Gonadal Stromal Tumor Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 24. Key Players Headquarters and Area Served
Table 25. Key Players Sex Cord Gonadal Stromal Tumor Treatment Product Solution and Service
Table 26. Date of Enter into Sex Cord Gonadal Stromal Tumor Treatment Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 29. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Share by Type (2015-2020)
Table 30. Global Sex Cord Gonadal Stromal Tumor Treatment Revenue Market Share by Type (2021-2026)
Table 31. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Share by Application (2015-2020)
Table 32. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 33. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size Share by Application (2021-2026)
Table 34. North America Key Players Sex Cord Gonadal Stromal Tumor Treatment Revenue (2019-2020) (Million US$)
Table 35. North America Key Players Sex Cord Gonadal Stromal Tumor Treatment Market Share (2019-2020)
Table 36. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 37. North America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2015-2020)
Table 38. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 39. North America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2015-2020)
Table 40. Europe Key Players Sex Cord Gonadal Stromal Tumor Treatment Revenue (2019-2020) (Million US$)
Table 41. Europe Key Players Sex Cord Gonadal Stromal Tumor Treatment Market Share (2019-2020)
Table 42. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 43. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2015-2020)
Table 44. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 45. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2015-2020)
Table 46. China Key Players Sex Cord Gonadal Stromal Tumor Treatment Revenue (2019-2020) (Million US$)
Table 47. China Key Players Sex Cord Gonadal Stromal Tumor Treatment Market Share (2019-2020)
Table 48. China Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 49. China Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2015-2020)
Table 50. China Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 51. China Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2015-2020)
Table 52. Japan Key Players Sex Cord Gonadal Stromal Tumor Treatment Revenue (2019-2020) (Million US$)
Table 53. Japan Key Players Sex Cord Gonadal Stromal Tumor Treatment Market Share (2019-2020)
Table 54. Japan Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 55. Japan Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2015-2020)
Table 56. Japan Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 57. Japan Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2015-2020)
Table 58. Southeast Asia Key Players Sex Cord Gonadal Stromal Tumor Treatment Revenue (2019-2020) (Million US$)
Table 59. Southeast Asia Key Players Sex Cord Gonadal Stromal Tumor Treatment Market Share (2019-2020)
Table 60. Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 61. Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2015-2020)
Table 62. Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 63. Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2015-2020)
Table 64. India Key Players Sex Cord Gonadal Stromal Tumor Treatment Revenue (2019-2020) (Million US$)
Table 65. India Key Players Sex Cord Gonadal Stromal Tumor Treatment Market Share (2019-2020)
Table 66. India Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 67. India Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2015-2020)
Table 68. India Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 69. India Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2015-2020)
Table 70. Central & South America Key Players Sex Cord Gonadal Stromal Tumor Treatment Revenue (2019-2020) (Million US$)
Table 71. Central & South America Key Players Sex Cord Gonadal Stromal Tumor Treatment Market Share (2019-2020)
Table 72. Central & South America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Type (2015-2020) (Million US$)
Table 73. Central & South America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type (2015-2020)
Table 74. Central & South America Sex Cord Gonadal Stromal Tumor Treatment Market Size by Application (2015-2020) (Million US$)
Table 75. Central & South America Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application (2015-2020)
Table 76. Abbott Company Details
Table 77. Abbott Business Overview
Table 78. Abbott Product
Table 79. Abbott Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 80. Abbott Recent Development
Table 81. Danaher Company Details
Table 82. Danaher Business Overview
Table 83. Danaher Product
Table 84. Danaher Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 85. Danaher Recent Development
Table 86. Roche Company Details
Table 87. Roche Business Overview
Table 88. Roche Product
Table 89. Roche Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 90. Roche Recent Development
Table 91. BD Company Details
Table 92. BD Business Overview
Table 93. BD Product
Table 94. BD Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 95. BD Recent Development
Table 96. Boston Scientific Company Details
Table 97. Boston Scientific Business Overview
Table 98. Boston Scientific Product
Table 99. Boston Scientific Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 100. Boston Scientific Recent Development
Table 101. Johnson & Johnson Company Details
Table 102. Johnson & Johnson Business Overview
Table 103. Johnson & Johnson Product
Table 104. Johnson & Johnson Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 105. Johnson & Johnson Recent Development
Table 106. Bio-Rad Company Details
Table 107. Bio-Rad Business Overview
Table 108. Bio-Rad Product
Table 109. Bio-Rad Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 110. Bio-Rad Recent Development
Table 111. Merck Millipore Business Overview
Table 112. Merck Millipore Product
Table 113. Merck Millipore Company Details
Table 114. Merck Millipore Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 115. Merck Millipore Recent Development
Table 116. Agilent Technologies Company Details
Table 117. Agilent Technologies Business Overview
Table 118. Agilent Technologies Product
Table 119. Agilent Technologies Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 120. Agilent Technologies Recent Development
Table 121. Thermo Fisher Scientific Company Details
Table 122. Thermo Fisher Scientific Business Overview
Table 123. Thermo Fisher Scientific Product
Table 124. Thermo Fisher Scientific Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 125. Thermo Fisher Scientific Recent Development
Table 126. Qiagen Company Details
Table 127. Qiagen Business Overview
Table 128. Qiagen Product
Table 129. Qiagen Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 130. Qiagen Recent Development
Table 131. PerkinElmer Company Details
Table 132. PerkinElmer Business Overview
Table 133. PerkinElmer Product
Table 134. PerkinElmer Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 135. PerkinElmer Recent Development
Table 136. CooperSurgical Company Details
Table 137. CooperSurgical Business Overview
Table 138. CooperSurgical Product
Table 139. CooperSurgical Revenue in Sex Cord Gonadal Stromal Tumor Treatment Business (2015-2020) (Million US$)
Table 140. CooperSurgical Recent Development
Table 141. Research Programs/Design for This Report
Table 142. Key Data Information from Secondary Sources
Table 143. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Type: 2020 VS 2026
Figure 2. Chemotherapy Features
Figure 3. Radiotherapy Features
Figure 4. Surgery Features
Figure 5. Others Features
Figure 6. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Application: 2020 VS 2026
Figure 7. Hospitals Case Studies
Figure 8. Clinics Case Studies
Figure 9. Cancer Research Centers Case Studies
Figure 10. Others Case Studies
Figure 11. Sex Cord Gonadal Stromal Tumor Treatment Report Years Considered
Figure 12. Global Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Regions: 2020 VS 2026
Figure 14. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global Sex Cord Gonadal Stromal Tumor Treatment Market Share by Players in 2019
Figure 17. Global Top Sex Cord Gonadal Stromal Tumor Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Sex Cord Gonadal Stromal Tumor Treatment as of 2019
Figure 18. The Top 10 and 5 Players Market Share by Sex Cord Gonadal Stromal Tumor Treatment Revenue in 2019
Figure 19. North America Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America Sex Cord Gonadal Stromal Tumor Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Bottom-up and Top-down Approaches for This Report
Figure 27. Data Triangulation
Figure 28. Key Executives Interviewed
性腺性腺間質腫瘍の世界市場（～2026年） The sex cord-gonadal stromal tumor is a rare type of cancer derived from the stromal component of the ovary and testis. This tumor comprises granulosa, thecal cells, and fibrocytes. Sex cord-gonadal stromal tumors are mostly of seven types, namely, granulosa cell tumor, Sertoli cell tumor, thecoma, …- 消化管間質腫瘍（GIST）の世界市場（～2026年） Gastrointestinal stromal tumors (GISTs) start in special cells in the wall of the gastrointestinal (GI) tract, also known as the digestive tract. Treatment of gastrointestinal stromal tumor is multidisciplinary, entailing the involvement of medical oncologists, surgeons, radiologist, as well as path…
- 消化管間質腫瘍（GIST）治療の世界市場（～2026年） A Gastrointestinal Stromal Tumor (GIST) is a type of tumor which occurs in the gastrointestinal tract and most commonly in the stomach or small intestine. Market Analysis and Insights: Global Gastrointestinal Stromal Tumors (GISTs) Treatment Market The global Gastrointestinal Stromal Tumors (GISTs) …
- 交流電場腫瘍治療の世界市場（～2026年） Alternating electric field tumor therapy is an anticancer treatment which disrupts the tumor cells mitosis. Alternating electric field therapy is a low intensity technique which disrupts the division of cells through physical interaction of molecules during mitosis in tumor cancer. The alternating e…
- 消化管間質腫瘍（GIST）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Gastrointestinal Stromal Tumor (GIST) Drug Market The global Gastrointestinal Stromal Tumor (GIST) Drug market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Gastrointestinal Stromal Tumo…